Back to Search
Start Over
Association of serum zinc level and clinical outcome in Egyptian COVID-19 patients.
- Source :
- Egyptian Journal of Internal Medicine; 9/24/2022, Vol. 34 Issue 1, p1-6, 6p
- Publication Year :
- 2022
-
Abstract
- Background: Zinc is an anti-inflammatory and antioxidant micronutrient found in food. Due to its well-established role in immunity, it is currently being used in some clinical trials against coronavirus disease-2019 (COVID-19). This study aimed to assess the association between the mean serum zinc level in COVID-19 Egyptian patients and its relationship with disease severity. This cross-sectional study was conducted on sixty patients with confirmed COVID-19 infection. These patients were divided into two groups according to clinical outcome, group 1 which included 30 intensive care unit (ICU) patients and group 2 which included 30 patients who were admitted to the ward. Mean serum levels of zinc were compared between the two groups. Results: There was a statistically significant difference noted among study groups regarding the serum zinc level (p < 0.039), where lower mean serum zinc levels were noted in ICU patients compared to ward patients (70.6 ± 5.7 vs 73.8 ± 6.1). Conclusion: Low serum zinc level is associated with the severe outcome of COVID-19 infection. [ABSTRACT FROM AUTHOR]
- Subjects :
- COVID-19
ZINC
IMMUNITY
ANTI-inflammatory agents
MICRONUTRIENTS
Subjects
Details
- Language :
- English
- ISSN :
- 11107782
- Volume :
- 34
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Egyptian Journal of Internal Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 159303564
- Full Text :
- https://doi.org/10.1186/s43162-022-00159-z